Trial intelligence / Profile preview

ECT and Brain Plasticity in Elderly Depressed Patients

NCT02667353Completed

Sponsor
UZ Leuven
Start
Jun 2011
Primary completion
Jun 2014
01

Overview

Open-label trial in major depressive disorder (MDD), sponsored by UZ Leuven. Primary endpoints: Change in hippocampal volume at 6 months, Change in brain derived neurotrophic factor at 4 weeks and 1 more. Started Jun 2011; status: completed.

02

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02667353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02667353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call